Skip to main content

Sonia García García

Institutions of which they are part

Research technician
Basic, Translational and Clinical Pharmacy Research
Vall Hebron Institut de Recerca

Sonia García García

Institutions of which they are part

Research technician
Basic, Translational and Clinical Pharmacy Research
Vall Hebron Institut de Recerca

Projects

CARACTERIZACIÓNDE LA FARMACOCINÈTICA DE RITUXIMAB EN PACIENTS AMB MALALTIES RENALS AMB AFECTACIÓ GLOMERULAR

IP: Maria Larrosa Garcia
Collaborators: Mónica Martínez Gallo, J. Bruno Montoro Ronsano, Maria Queralt Gorgas Torner, Irene Agraz Pamplona, Carla Alonso Martinez, Maria Teresa Sanz Martinez, Sonia García García
Funding agency: Societat Catalana de Farmàcia Clínica
Funding: 12000
Reference: SCFC/JOAQUIM.BONAL/2022/LARROSA
Duration: 01/09/2022 - 30/08/2024

Desarrollo de dos modelos farmacocinéticos poblacionales, uno de infliximab y otro de adalimumab, en pacientes pediátricos con enfermedad inflamatoria intestinal incluyendo variantes farmacogenéticas.

IP: Susana Clemente Bautista
Collaborators: Maria José Cabañas Poy, Oscar Segarra Canton, Marina Álvarez Beltrán, Sonia García García
Funding agency: Sociedad Española de Farmacia Hospitalaria
Funding: 6240
Reference: 2021/SEFH/FARMACIA/CLEMENTE
Duration: 06/09/2022 - 31/12/2024

Related news

Within the framework of a clinical trial, the first 3D printed medicine in Europe in the pediatric field will be tested.

Related professionals

Mª Jesús Cruz Carmona

Mª Jesús Cruz Carmona

Head of group
Pneumology
Read more
Mª Carmen López  Arribas

Mª Carmen López Arribas

Research technician
Molecular Medical Imaging
Read more
Teresa Vendrell Bayona

Teresa Vendrell Bayona

Genetics Medicine
Read more
Josep Castellví Vives

Josep Castellví Vives

Translational Molecular Pathology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.